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Contamination of bronchoscopes is well
described.1–3 However, while cleaning
and disinfecting bronchoscopes are
clearly described in standardisation docu-
ments,1–3 the performance of a control
sample prior to bronchoscopy is not sug-
gested.4 5 Here, we offer an argument
for such a procedure, supported by our
experience with a 2-year-old boy with
cystic fibrosis who underwent flexible
bronchoscopy and bronchoalveolar lavage
(BAL).
The bronchoscope in question had been
used on a previous case on the same list,
then supposedly cleaned and decontami-
nated, prior to reuse. We performed a
‘control lavage’, by suctioning sterile
0.9% NaCl through the instrument
channel, before the boy’s procedure.
However, it was only afterwards that the
bronchoscopist noted the cloudy appear-
ance of the control sample, suggestive of
contamination. Subsequent investigation
determined that the scope had not been
adequately cleaned, due to human error,
despite availability of appropriate equip-
ment and standards.
BAL samples from the first case on the
list, the control sample, and the index case
were positive for Haemophilus influenzae.
Molecular typing demonstrated that the H
influenzae from the first case, and the
control sample, were identical, but distinct
from that found in the index case. The
patient was pyrexial and coughing within
24 h of the procedure. The symptoms
gradually resolved over 6 weeks, while on
broad-spectrum antibiotic cover.
Our case suggests potential benefits of
performing a simple ‘control lavage’.
First, a contaminated bronchoscope will
result in ‘false-positive’ BAL results. The
control BAL sample is the only way to
detect this error and avoid inappropriate
treatment. Second, the BAL culture results
may be ‘true-positives’, with the pathogen
flushed into the patient’s airways during
lavage. This is an iatrogenic infection and
a gross medical error. Left undetected the
error can be repeated in multiple patients,
on multiple lists. Obtaining a control BAL
provides an opportunity to limit ‘out-
breaks’ of bronchoscope contamination to
one list. Finally, where gross contamin-
ation is discovered, it will be possible to
halt the procedure, thus avoiding the
nosocomial infection. These recommenda-
tions may not be relevant to adult patients
undergoing diagnostic bronchoscopy for
assessment of lung cancer.
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